Publication | Closed Access

Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) combination therapy through impairing intracellular ATP production and DNA repair in breast cancer stem cells

Breast OncologyOncologyMedicineCell DeathIntracellular Atp ProductionBreast CancerCombination TherapyAnti-cancer AgentCancer TreatmentPharmacologyCell Biology